Annual FCF
-$279.04 M
+$230.08 M+45.19%
31 December 2023
Summary:
PTC Therapeutics annual free cash flow is currently -$279.04 million, with the most recent change of +$230.08 million (+45.19%) on 31 December 2023. During the last 3 years, it has fallen by -$28.99 million (-11.59%). PTCT annual FCF is now -1233.07% below its all-time high of -$20.93 million, reached on 31 December 2011.PTCT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$87.77 M
-$23.69 M-36.97%
30 September 2024
Summary:
PTC Therapeutics quarterly free cash flow is currently -$87.77 million, with the most recent change of -$23.69 million (-36.97%) on 30 September 2024. Over the past year, it has dropped by -$44.04 million (-100.73%). PTCT quarterly FCF is now -556.06% below its all-time high of $19.25 million, reached on 31 December 2017.PTCT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$274.19 M
-$44.04 M-19.14%
30 September 2024
Summary:
PTC Therapeutics TTM free cash flow is currently -$274.19 million, with the most recent change of -$44.04 million (-19.14%) on 30 September 2024. Over the past year, it has increased by +$69.06 million (+20.12%). PTCT TTM FCF is now -77335.49% below its all-time high of $355.00 thousand, reached on 30 September 2018.PTCT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.2% | -100.7% | +20.1% |
| 3 y3 years | -11.6% | -14.0% | +16.2% |
| 5 y5 years | -546.4% | -213.2% | -93.0% |
PTCT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.6% | +45.2% | -1469.2% | +54.5% | -37.5% | +46.1% |
| 5 y | 5 years | -546.4% | +45.2% | -1469.2% | +54.5% | -93.0% | +46.1% |
| alltime | all time | -1233.1% | +45.2% | -556.1% | +54.5% | <-9999.0% | +46.1% |
PTC Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$87.77 M(+37.0%) | -$274.19 M(+19.1%) |
| June 2024 | - | -$64.08 M(-1099.7%) | -$230.14 M(+15.4%) |
| Mar 2024 | - | $6.41 M(-105.0%) | -$199.47 M(-28.5%) |
| Dec 2023 | -$279.04 M(-45.2%) | -$128.75 M(+194.5%) | -$279.04 M(-18.7%) |
| Sept 2023 | - | -$43.73 M(+30.9%) | -$343.25 M(-5.6%) |
| June 2023 | - | -$33.40 M(-54.3%) | -$363.59 M(-9.9%) |
| Mar 2023 | - | -$73.16 M(-62.1%) | -$403.42 M(-20.8%) |
| Dec 2022 | -$509.11 M(+51.2%) | -$192.96 M(+201.2%) | -$509.11 M(+24.5%) |
| Sept 2022 | - | -$64.07 M(-12.5%) | -$409.03 M(-3.1%) |
| June 2022 | - | -$73.23 M(-59.1%) | -$421.96 M(+6.7%) |
| Mar 2022 | - | -$178.85 M(+92.6%) | -$395.50 M(+17.5%) |
| Dec 2021 | -$336.66 M(+34.6%) | -$92.88 M(+20.6%) | -$336.66 M(+2.9%) |
| Sept 2021 | - | -$77.00 M(+64.7%) | -$327.02 M(+30.9%) |
| June 2021 | - | -$46.77 M(-61.0%) | -$249.86 M(-7.8%) |
| Mar 2021 | - | -$120.02 M(+44.2%) | -$271.06 M(+8.4%) |
| Dec 2020 | -$250.05 M(+73.6%) | -$83.23 M(<-9900.0%) | -$250.05 M(+29.5%) |
| Sept 2020 | - | $155.00 K(-100.2%) | -$193.10 M(-12.7%) |
| June 2020 | - | -$67.96 M(-31.4%) | -$221.28 M(+11.9%) |
| Mar 2020 | - | -$99.01 M(+276.6%) | -$197.81 M(+37.3%) |
| Dec 2019 | -$144.08 M(+233.7%) | -$26.29 M(-6.2%) | -$144.08 M(+1.4%) |
| Sept 2019 | - | -$28.02 M(-37.0%) | -$142.07 M(+22.6%) |
| June 2019 | - | -$44.49 M(-1.7%) | -$115.87 M(+60.7%) |
| Mar 2019 | - | -$45.27 M(+86.5%) | -$72.09 M(+67.0%) |
| Dec 2018 | -$43.17 M | -$24.28 M(+1228.3%) | -$43.17 M(<-9900.0%) |
| Sept 2018 | - | -$1.83 M(+159.3%) | $355.00 K(-100.4%) |
| June 2018 | - | -$705.00 K(-95.7%) | -$91.23 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$16.36 M(-185.0%) | -$77.56 M(-14.1%) |
| Dec 2017 | -$90.33 M(-14.3%) | $19.25 M(-120.6%) | -$90.33 M(-27.2%) |
| Sept 2017 | - | -$93.41 M(-820.4%) | -$124.13 M(+125.5%) |
| June 2017 | - | $12.97 M(-144.5%) | -$55.06 M(-40.6%) |
| Mar 2017 | - | -$29.13 M(+100.1%) | -$92.62 M(-12.1%) |
| Dec 2016 | -$105.34 M(-17.1%) | -$14.55 M(-40.2%) | -$105.34 M(-13.7%) |
| Sept 2016 | - | -$24.34 M(-1.0%) | -$122.08 M(-3.2%) |
| June 2016 | - | -$24.59 M(-41.2%) | -$126.08 M(-4.2%) |
| Mar 2016 | - | -$41.85 M(+33.8%) | -$131.60 M(+3.6%) |
| Dec 2015 | -$127.06 M(+105.1%) | -$31.29 M(+10.4%) | -$127.06 M(+18.4%) |
| Sept 2015 | - | -$28.35 M(-5.9%) | -$107.27 M(+11.4%) |
| June 2015 | - | -$30.11 M(-19.3%) | -$96.28 M(+12.4%) |
| Mar 2015 | - | -$37.31 M(+224.4%) | -$85.62 M(+38.2%) |
| Dec 2014 | -$61.94 M(+29.7%) | -$11.50 M(-33.7%) | -$61.94 M(-5.1%) |
| Sept 2014 | - | -$17.36 M(-10.8%) | -$65.27 M(+22.1%) |
| June 2014 | - | -$19.46 M(+42.8%) | -$53.47 M(-0.1%) |
| Mar 2014 | - | -$13.62 M(-8.2%) | -$53.52 M(+12.0%) |
| Dec 2013 | -$47.77 M(-0.7%) | -$14.84 M(+167.1%) | -$47.77 M(+8.6%) |
| Sept 2013 | - | -$5.55 M(-71.5%) | -$43.98 M(-1.4%) |
| June 2013 | - | -$19.51 M(+148.0%) | -$44.62 M(+13.7%) |
| Mar 2013 | - | -$7.87 M(-28.7%) | -$39.25 M(-18.4%) |
| Dec 2012 | -$48.12 M(+129.9%) | -$11.04 M(+78.1%) | -$48.12 M(+29.8%) |
| Sept 2012 | - | -$6.20 M(-56.1%) | -$37.07 M(+20.1%) |
| June 2012 | - | -$14.14 M(-15.5%) | -$30.87 M(+84.5%) |
| Mar 2012 | - | -$16.74 M | -$16.74 M |
| Dec 2011 | -$20.93 M | - | - |
FAQ
- What is PTC Therapeutics annual free cash flow?
- What is the all time high annual FCF for PTC Therapeutics?
- What is PTC Therapeutics annual FCF year-on-year change?
- What is PTC Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for PTC Therapeutics?
- What is PTC Therapeutics quarterly FCF year-on-year change?
- What is PTC Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for PTC Therapeutics?
- What is PTC Therapeutics TTM FCF year-on-year change?
What is PTC Therapeutics annual free cash flow?
The current annual FCF of PTCT is -$279.04 M
What is the all time high annual FCF for PTC Therapeutics?
PTC Therapeutics all-time high annual free cash flow is -$20.93 M
What is PTC Therapeutics annual FCF year-on-year change?
Over the past year, PTCT annual free cash flow has changed by +$230.08 M (+45.19%)
What is PTC Therapeutics quarterly free cash flow?
The current quarterly FCF of PTCT is -$87.77 M
What is the all time high quarterly FCF for PTC Therapeutics?
PTC Therapeutics all-time high quarterly free cash flow is $19.25 M
What is PTC Therapeutics quarterly FCF year-on-year change?
Over the past year, PTCT quarterly free cash flow has changed by -$44.04 M (-100.73%)
What is PTC Therapeutics TTM free cash flow?
The current TTM FCF of PTCT is -$274.19 M
What is the all time high TTM FCF for PTC Therapeutics?
PTC Therapeutics all-time high TTM free cash flow is $355.00 K
What is PTC Therapeutics TTM FCF year-on-year change?
Over the past year, PTCT TTM free cash flow has changed by +$69.06 M (+20.12%)